Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine...

Area of Science:

• Virology
• Epidemiology
• Public Health

Background:

• The COVID-19 pandemic caused global disruption, necessitating research into SARS-CoV-2 and related human coronaviruses.
• Understanding coronavirus phylogeny, transmission, and management is crucial for developing novel therapeutics and vaccines.
• Common symptoms across MERS, SARS-CoV, and SARS-CoV-2 include fever, cough, and dyspnea, potentially progressing to severe respiratory illness.

Purpose of the Study:

• To analyze the phylogenetic relationships, transmission dynamics, and clinical management of human coronaviruses, focusing on SARS-CoV-2.
• To identify molecular targets for therapeutic development by understanding the SARS-CoV-2 entry and replication cycle.
• To leverage genomic data and past vaccine development efforts against SARS-CoV and MERS for future outbreak preparedness.

Main Methods:

• Phylogenetic analysis to trace the origin and spread of SARS-CoV-2.
• Comparative analysis of symptoms and disease progression across different human coronaviruses.
• Genomic and structural analysis of SARS-CoV-2 for identifying therapeutic and vaccine targets.

Main Results:

• Phylogenetic analysis confirms SARS-CoV-2 emerged in late 2019 and spread globally from Wuhan.
• Multiple SARS-CoV-2 variants have been identified, highlighting the virus's adaptability.
• Understanding viral entry and replication pathways offers targets for novel therapeutics.

Conclusions:

• Comparative analysis of human coronaviruses informs the development of effective treatments and vaccines.
• Genomic insights and prior vaccine research accelerate the response to emerging infectious diseases.
• A coordinated global response is vital for rapidly addressing pandemic threats like COVID-19.